SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-052872
Filing Date
2024-05-03
Accepted
2024-05-03 16:05:10
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3939
  Complete submission text file 0000950170-24-052872.txt   5362
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TSCAN THERAPEUTICS, INC. 880 WINTER STREET WALTHAM MA 02451
Business Address
Louis Chrystal (Reporting) CIK: 0002018696 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 24912959